STLR Link Roundup – April 2, 2010

The latest on the STLR radar: The Southern District of New York‘s decision in Association for Molecular Pathology and ACLU v. USPTO and Myriad (the “gene patents case”) handed down last Monday, has generated a lot of commentary this week. Here’s a selection: reports from Wired and On the Edges of Science and Law; IP Watchdog describes the ruling as “inane”; Patent Docs gives more detail on the patents at issue; Patently O thinks the Federal Continue Reading →

Court Allows Challenge to Patents on Breast Cancer Genes

Judge Robert Sweet in the U.S. District Court for the Southern District of New York has allowed a challenge to two gene patents owned by Myriad Genetics.  The ACLU, on behalf of scientific organizations, researchers, genetic counselors, and individual women, is contesting the validity of gene patents in general, and is challenging the patents on the BRCA-1 and BRCA-2 genes in particular.  The complaint alleges that gene patents are unpatentable subject matter under 35 U.S.C Continue Reading →